These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32800281)

  • 61. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer.
    Supiot S; Bennouna J; Rio E; Meurette G; Bardet E; Buecher B; Dravet F; Le Neel JC; Douillard JY; Mahé MA; Lehur PA
    Colorectal Dis; 2006 Jun; 8(5):430-5. PubMed ID: 16684088
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Corrigendum to "Indications for and results of axillary arterio-venous fistula in patients with a functionally single ventricle after cavopulmonary anastomosis" [Eur J Cardiothorac Surg 2019;55:572-578]†.
    Yurlov IA; Podzolkov VP; Kovalev DV; Chugueva IA; Zelenikin MM; Samsonov VB; Chikin NS; Yurpol'skay LA; Mataeva TV
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):599. PubMed ID: 30698689
    [No Abstract]   [Full Text] [Related]  

  • 64. Failure to report ethical approval and informed consent in paediatric surgical publications.
    Dingemann J; Dingemann C; Ure B
    Eur J Pediatr Surg; 2011 Aug; 21(4):215-9. PubMed ID: 21590657
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Controversies and progress in adjuvant chemotherapy for patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy].
    Li XX; Li QG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):594-596. PubMed ID: 31238639
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of locally advanced rectal cancer.
    Klaassen RA; Nieuwenhuijzen GA; Martijn H; Rutten HJ; Hospers GA; Wiggers T
    Surg Oncol; 2004; 13(2-3):137-47. PubMed ID: 15572096
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Corrigendum to "Bereavement stressors and psychosocial well-being of young adults following the loss of a parent - A cross-sectional survey" [Eur. J. Oncol. Nurs. 35 (2018) 33-38].
    Lundberg T; Forinder U; Olsson M; Fürst CJ; Årestedt K; Alvariza A
    Eur J Oncol Nurs; 2019 Jun; 40():1. PubMed ID: 31229197
    [No Abstract]   [Full Text] [Related]  

  • 68. Outcome after the introduction of a multimodality treatment program for locally advanced rectal cancer.
    Palmer G; Martling A; Blomqvist L; Cedermark B; Holm T
    Eur J Surg Oncol; 2005 Sep; 31(7):727-34. PubMed ID: 15979271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
    Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
    Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
    McCarthy K; Pearson K; Fulton R; Hewitt J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Peng H; Wang C; Xiao W; Lin X; You K; Dong J; Wang Z; Yu X; Zeng Z; Zhou T; Gao Y; Wen B
    J Cancer; 2018; 9(15):2687-2692. PubMed ID: 30087709
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging.
    Larsen SG; Wiig JN; Emblemsvaag HL; Grøholt KK; Hole KH; Bentsen A; Dueland S; Vetrhus T; Giercksky KE
    Colorectal Dis; 2009 Sep; 11(7):759-67. PubMed ID: 18662240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment : results from a national cohort study.
    Lykke J; Jess P; Roikjaer O;
    Int J Colorectal Dis; 2015 Mar; 30(3):347-51. PubMed ID: 25652878
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Corrigendum to "COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer" [Eur. J. Radiol. 132 (2020) 109338].
    Zhao P; Pan Z; Yu T
    Eur J Radiol; 2020 Dec; 133():109401. PubMed ID: 33199189
    [No Abstract]   [Full Text] [Related]  

  • 77. Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer.
    Bibault JE; Giraud P; Housset M; Durdux C; Taieb J; Berger A; Coriat R; Chaussade S; Dousset B; Nordlinger B; Burgun A
    Sci Rep; 2018 Aug; 8(1):12611. PubMed ID: 30135549
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Corrigendum to "The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity" [Crit. Rev. Oncol./Hematol. 116 (2017) 82-88].
    Bossi P; Cossu Rocca M; Corvò R; Depenni R; Guardamagna V; Marinangeli F; Miccichè F; Trippa F
    Crit Rev Oncol Hematol; 2017 Nov; 119():29. PubMed ID: 29065982
    [No Abstract]   [Full Text] [Related]  

  • 79. Clinical algorithms for the surgical management of locally recurrent rectal cancer.
    Mirnezami AH; Sagar PM; Kavanagh D; Witherspoon P; Lee P; Winter D
    Dis Colon Rectum; 2010 Sep; 53(9):1248-57. PubMed ID: 20706067
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
    JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.